Drug recall · October 7, 2020
Nymalize recall
Why: Subpotent Drug
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer shipping carton, Rx Only, Distributed by arbor Atlanta, GA, NDC 24338-200-12
- Lots / codes
Lot #: 356884 Exp. 11/30/2021
- Quantity
- 1846 cartons
- Company
- Arbor Pharmaceuticals Inc., Atlanta, GA
- Distribution
- Nationwide within the United States
- Initiated
- September 16, 2020 · Voluntary: Firm initiated
- Classified
- September 28, 2020
- Reported
- October 7, 2020
- Ended
- February 22, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nimodipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.